Effects of Dapagliflozin on Volume Status When Added to Renin–Angiotensin System Inhibitors

Sodium glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of heart and kidney failure in patients with type 2 diabetes, possibly due to diuretic effects. Previous non-placebo-controlled studies with SGLT2 inhibitors observed changes in volume markers in healthy individuals and in patients w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Med
Main Authors: Eickhoff, Mie K., Dekkers, Claire C. J., Kramers, Bart J., Laverman, Gozewijn Dirk, Frimodt-Møller, Marie, Jørgensen, Niklas Rye, Faber, Jens, Danser, A. H. Jan, Gansevoort, Ron T., Rossing, Peter, Persson, Frederik, Heerspink, Hiddo J. L.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6616433/
https://ncbi.nlm.nih.gov/pubmed/31159350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8060779
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados